LYRA
USDLyra Therapeutics Inc. Common Stock
$12.830-0.500 (-3.751%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$13.330
High
$13.502
Low
$11.670
Volume
0.20M
Company Fundamentals
Market Cap
17.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.65M
Exchange
NCM
Currency
USD
52-Week Range
Low $3.81Current $12.830High $37.5
Related News
Analyst Upgrades
HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16
HC Wainwright & Co. analyst Matthew Caufield maintains Lyra Therapeutics with a Neutral and raises the price target from $2 to $16.
View more
GlobeNewswire
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)
ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078)ENLIGHTEN 2 trial also showed
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.